Citadel Advisors
BBC icon

Citadel Advisors’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Citadel Advisors’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.17M Sell
28,084
-12,839
-31% -$526K ﹤0.01% 7308
2025
Q4 		$1.58M Buy
+40,923
New +$1.39M ﹤0.01% 6402
2024
Q4 		– Sell
-34,631
Closed -$968K – 14487
2024
Q3 		$968K Sell
34,631
-5,469
-14% -$151K ﹤0.01% 6933
2024
Q2 		$1.01M Buy
+40,100
New +$1.07M ﹤0.01% 6548
2024
Q1 		– Sell
-37,327
Closed -$913K – 14545
2023
Q4 		$913K Buy
37,327
+1,815
+5% +$35.8K ﹤0.01% 6857
2023
Q3 		$697K Buy
35,512
+1,824
+5% +$40.5K ﹤0.01% 7348
2023
Q2 		$807K Buy
33,688
+925
+3% +$22.3K ﹤0.01% 6905
2023
Q1 		$718K Buy
+32,763
New +$824K ﹤0.01% 7501
2021
Q1 		– Sell
-12,801
Closed -$635K – 13150
2020
Q4 		$635K Buy
12,801
+2,083
+19% +$93.6K ﹤0.01% 7700
2020
Q3 		$418K Buy
+10,718
New +$437K ﹤0.01% 7586
2019
Q4 		– Sell
-13,951
Closed -$332K – 9100
2019
Q3 		$332K Buy
13,951
+5,834
+72% +$159K ﹤0.01% 7416
2019
Q2 		$234K Buy
+8,117
New +$227K ﹤0.01% 7960
2018
Q4 		– Sell
-18,447
Closed -$638K – 9089
2018
Q3 		$638K Buy
+18,447
New +$622K ﹤0.01% 6309
2017
Q1 		– Sell
-23,166
Closed -$426K – 7424
2016
Q4 		$426K Buy
+23,166
New +$462K ﹤0.01% 5158
2016
Q3 		– Sell
-16,139
Closed -$291K – 7225
2016
Q2 		$291K Buy
+16,139
New +$316K ﹤0.01% 5256
2016
Q1 		– Sell
-32,531
Closed -$945K – 6773
2015
Q4 		$945K Buy
32,531
+19,928
+158% +$576K ﹤0.01% 3648
2015
Q3 		$333K Buy
+12,603
New +$426K ﹤0.01% 5407

Other funds holding BBC

KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $454M AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
APW
Aurora Private Wealth Rockaway, New Jersey $140M AUM
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
GAA
Global Assets Advisory Orlando, Florida $349M AUM 24.2% 1-Year Est. Return

Citadel Advisors's BBC Position: Q1 2026 in Review

Citadel Advisors reduced its Virtus Biotech Clinical Trials ETF (BBC) stake by 31% in Q1 2026, selling an estimated $526K and leaving 28,084 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #7308.

Citadel Advisors first reported a position in BBC in Q3 2015 and has held it in 17 quarters since. The position peaked at $1.58M in Q4 2025. 20 funds tracked by Wall St. Rank hold BBC as of Q1 2026.

  • Citadel Advisors held 28,084 shares of Virtus Biotech Clinical Trials ETF worth $1.17M as of Q1 2026.
  • Citadel Advisors sold 12,839 Virtus Biotech Clinical Trials ETF shares in Q1 2026, an estimated $526K.
  • Virtus Biotech Clinical Trials ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7308 holding.
  • Citadel Advisors first reported a position in Virtus Biotech Clinical Trials ETF in Q3 2015 and has held it in 17 quarters since.
  • Citadel Advisors's Virtus Biotech Clinical Trials ETF position peaked at $1.58M in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.